The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growthKimberley Hanson, Grant N. Wheeler, Adam E. Hendry et al.|Oncotarget|2017Cited by 29
Combining Cytotoxicity Assessment and <i>Xenopus laevis</i> Phenotypic Abnormality Assay as a Predictor of Nanomaterial SafetyKaramallah Al‐Yousuf, Victoria Sherwood, Carl A Webster et al.|Current Protocols in Toxicology|2017Cited by 7
Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growthKimberley Hanson, Grant N. Wheeler, Victoria Sherwood et al.|Oncotarget|2018Cited by 1